Source: Forensic Toxicology. Unidade: FCF
Subjects: DROGAS DE ABUSO, CANABINOIDES
ABNT
ARAUJO, Karen Rafaela Gonçalves de et al. The mystery behind the apprehensions of the selective cannabinoid receptor type-2 agonist BZO-HEXOXIZID (MDA-19) as a drug of abuse. Forensic Toxicology, v. 41, p. 142–150, 2023Tradução . . Disponível em: https://doi.org/10.1007/s11419-022-00646-6. Acesso em: 31 out. 2024.APA
Araujo, K. R. G. de, Fabris, A. L., Neves Júnior, L. F., Ponce, J. de C., Soares, A. L., Costa, J. L. da, & Yonamine, M. (2023). The mystery behind the apprehensions of the selective cannabinoid receptor type-2 agonist BZO-HEXOXIZID (MDA-19) as a drug of abuse. Forensic Toxicology, 41, 142–150. doi:10.1007/s11419-022-00646-6NLM
Araujo KRG de, Fabris AL, Neves Júnior LF, Ponce J de C, Soares AL, Costa JL da, Yonamine M. The mystery behind the apprehensions of the selective cannabinoid receptor type-2 agonist BZO-HEXOXIZID (MDA-19) as a drug of abuse [Internet]. Forensic Toxicology. 2023 ; 41 142–150.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s11419-022-00646-6Vancouver
Araujo KRG de, Fabris AL, Neves Júnior LF, Ponce J de C, Soares AL, Costa JL da, Yonamine M. The mystery behind the apprehensions of the selective cannabinoid receptor type-2 agonist BZO-HEXOXIZID (MDA-19) as a drug of abuse [Internet]. Forensic Toxicology. 2023 ; 41 142–150.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s11419-022-00646-6